Latest News & Features
Americas
Research and development, strong IP rights and good international relations are all factors in Brazil’s rise as a soybean-producing powerhouse, as Gabriel Di Blasi and Matheus Gil do Amaral of Di Blasi Parente & Associados report. 29 May 2018
Americas
Molecular diagnostics company Myriad Genetics has agreed to acquire Counsyl, a genetic screening company, for $375 million. 29 May 2018
Americas
Pfizer has sued Canadian pharmaceutical company Apotex over its plan to make and sell a generic version of Pfizer’s Inlyta tablets. 29 May 2018
Big Pharma
The European Commission has proposed a change in IP rules to allow pharmaceutical companies to produce generic drugs for export to non-EU countries that don’t have patent protection. 29 May 2018
Americas
A judge has found it unlikely that Impax Laboratories would launch a generic drug before a final court decision in related patent litigation and has dismissed a case against the company. 25 May 2018
Americas
Pharmaceutical company UCB has emerged victorious in a case against major generic drug companies after its patent win was affirmed on appeal. 24 May 2018
Americas
Animal health company Boehringer Ingelheim Vetmedica has sued Merck & Co and Merck Animal Health for infringing three patents covering vaccines for treating pig disease. 23 May 2018
Americas
Corteva Agriscience, the agriculture division of DowDuPont, has signed a licensing deal with Monsanto to use its technology for fighting insects found on corn. 23 May 2018
Americas
Pharmaceutical companies Lundbeck and Takeda have sued generic drug producer Lupin for infringing a patent directed to anti-depressant medication Trintellix (vortioxetine hydrobromide). 23 May 2018
Big Pharma
The UK Intellectual Property Office has published several proposals, including some addressing barriers to growth for IP-rich companies, in response to received views of IP with regard to the government’s Industrial Strategy. 22 May 2018